Accelerated communication: Effect of combination interleukin-1 and erythropoietin in ameliorating the hematopoietic toxicity associated with the use of zidovudine administered to normal mice

This publication has 13 references indexed in Scilit:

• Sustained zidovudine treatment on hematopoiesis in immunodeficient mice
  International Journal of Immunopharmacology, 1993
• Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine
  New England Journal of Medicine, 1990
• In vivo toxicity of 3′‐azido‐3′‐deoxythymidine (ALT) on CBA/CA mice
  The International Journal of Cell Cloning, 1990
• 3′‐Azido‐3′‐deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells
  British Journal of Haematology, 1988
• Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Developmental Therapeutics and the Acquired Immunodeficiency Syndrome
  Annals of Internal Medicine, 1987
• Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro
  Antimicrobial Agents and Chemotherapy, 1987
• Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
  Proceedings of the National Academy of Sciences, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986